Skip to content
InVision Medical Technology logo

InVision Medical Technology

InVision Medical Technology is a YC Summer 2022 (S22) company. Team of 2.

  • Artificial Intelligence
  • Health Tech
  • Diagnostics

About InVision Medical Technology

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

InVision Medical Technology builds FDA-cleared AI software for echocardiography, the most common cardiac imaging exam. Cardiologists and echo lab technicians use it to automate measurements, standardize interpretation, and flag conditions such as cardiac amyloidosis that manual reads miss. It replaces time-consuming physician review of ultrasound studies and the manual grading work that today goes undetected or inconsistent across labs.

Business model

Per-eligible-inpatient-stay reimbursement via Medicare NTAP, plus outpatient coverage under CPT Category III code 0932T billed to health systems

Go-to-market

Health system cardiovascular service lines are the buyers; sales are led by InVision's team and supported by FDA clearance, peer-reviewed clinical evidence, and an established reimbursement path that gives procurement teams a concrete financial case.

From the Y Combinator listing

How InVision Medical Technology describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

AI Diagnosis of Heart Disease

At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.

Facts

Industry
Healthcare / Healthcare
Team size
2
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works